Package 31722-006-31

{"route": ["ORAL"], "spl_id": "2cd3622f-a50f-ec9c-e063-6294a90a3a30", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "upc": ["0331722006316"], "unii": ["304NUG5GF4"], "rxcui": ["348506"], "spl_set_id": ["5af0b33d-bfa6-420b-86f0-067f95b402b2"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (31722-006-31)  / 150 mL in 1 BOTTLE, GLASS", "package_ndc": "31722-006-31", "marketing_start_date": "20200901"}], "brand_name": "Itraconazole", "product_id": "31722-006_2cd3622f-a50f-ec9c-e063-6294a90a3a30", "dosage_form": "SOLUTION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "31722-006", "generic_name": "Itraconazole", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Itraconazole", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "10 mg/mL"}], "application_number": "ANDA212239", "marketing_category": "ANDA", "marketing_start_date": "20200901", "listing_expiration_date": "20261231"}